Research graph
References from Living donor liver transplantation in transplant oncology: A disease-specific framework for access, timing, and donor risk. Local targets link to admitted publications; unresolved targets remain external evidence.
Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation
10.1111/j.1600-6143.2007.01802.x · 2007 · External reference
Outcomes of living and deceased donor liver transplant recipients with hepatocellular carcinoma: results of the A2ALL cohort
10.1111/j.1600-6143.2012.04272.x · 2012 · External reference
Living or deceased organ donors in liver transplantation for hepatocellular carcinoma: a systematic review and meta-analysis
10.1016/j.hpb.2018.11.004 · 2019 · External reference
Hepatocellular carcinoma recurrence in living and deceased donor liver transplantation: a systematic review and meta-analysis
10.1097/cm9.0000000000000287 · 2019 · External reference
National experience with living donor liver transplantation for hepatocellular carcinoma
10.1002/lt.26439 · 2022 · External reference
Live donor liver transplantation for patients with hepatocellular carcinoma offers increased survival vs. deceased donation
10.1016/j.jhep.2018.12.029 · 2019 · External reference
Japanese liver transplantation society. Expanded living-donor liver transplantation criteria for patients with hepatocellular carcinoma based on the Japanese nationwide survey: the 5-5-500 rule—a retrospective study
10.1111/tri.13391 · 2019 · External reference
Living donor liver transplantation for perihilar cholangiocarcinoma: outcomes and complications
10.1016/j.jamcollsurg.2019.12.037 · 2020 · External reference
Safety and efficacy of living donor liver transplantation for unresectable perihilar cholangiocarcinoma: a single center prospective study
10.1002/jhbp.12121 · 2025 · External reference
Living donor liver transplantation for intrahepatic cholangiocarcinoma
10.3390/curroncol29030157 · 2022 · External reference
Living donor liver transplant for intrahepatic cholangiocarcinoma. An initial Brazilian experience
10.1590/0102-6720202400045e1839 · 2024 · External reference
Neoadjuvant pemigatinib as a bridge to living donor liver transplantation for intrahepatic cholangiocarcinoma with FGFR2 gene rearrangement
10.1016/j.ajt.2024.10.023 · 2025 · External reference
Living donor liver transplantation for neoadjuvant-treated, unresectable intrahepatic cholangiocarcinoma (LIVINCA): study protocol for a one-armed, monocentric, non-randomized trial
10.1159/000545871 · 2025 · External reference
Unresolved reference
External reference
Living donor liver transplantation: a life-saving option in emergency situations for diffuse hepatic neuroendocrine tumor metastasis
10.1016/j.transproceed.2014.12.017 · 2015 · External reference
Liver transplantation for gastroenteropancreatic neuroendocrine liver metastasis: optimal patient selection and perioperative management in the era of multimodal treatments
10.1007/s00535-024-02166-z · 2025 · External reference
Recipient and donor outcomes after living-donor liver transplant for unresectable colorectal liver metastases
10.1001/jamasurg.2022.0300 · 2022 · External reference
Toronto management of initially unresectable liver metastasis from colorectal cancer in a living donor liver transplant program
10.1097/xcs.0000000000000734 · 2023 · External reference
The Rochester protocol for living donor liver transplantation of unresectable colorectal liver metastasis: a 5-year report on selection, approval, and outcomes
10.1016/j.ajt.2024.09.027 · 2025 · External reference
Living-donor liver transplantation for non-resectable colorectal liver metastases: protocol for a multicentric, single-arm study
10.1136/bmjopen-2024-088188 · 2024 · External reference
Can living donor liver transplantation provide similar outcomes to deceased-donor liver transplantation for hepatocellular carcinoma? A systematic review and meta-analysis
10.1007/s12072-022-10435-3 · 2023 · External reference
Living donor liver transplantation for hepatocellular carcinoma within and outside traditional selection criteria: a multicentric north American experience
10.1097/sla.0000000000006049 · 2024 · External reference
Japanese living donor liver transplantation criteria for hepatocellular carcinoma: nationwide cohort study
10.1093/bjsopen/zrae079 · 2024 · External reference
Long-term prognostic value of AFP and PIVKA-II in hepatocellular carcinoma after living donor liver transplantation: a single-center retrospective study
10.3389/ti.2025.14748 · 2025 · External reference
Validation of the R3-AFP model for risk prediction of HCC recurrence after liver transplantation in the SiLVER randomized clinical trial
10.1097/lvt.0000000000000487 · 2025 · External reference
Long-term outcomes in deceased versus living donor liver transplantation for hepatocellular carcinoma: a bi-institutional study of 486 cases
10.1007/s00464-025-12011-w · 2025 · External reference
Comparison between liver transplantation and resection for hilar cholangiocarcinoma: a systematic review and meta-analysis
10.1371/journal.pone.0220527 · 2019 · External reference
Liver transplantation for hilar cholangiocarcinoma: a systematic review
10.1016/j.trre.2019.100516 · 2020 · External reference
Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers
10.1053/j.gastro.2012.04.008 · 2012 · External reference
The 2024 ILTS-ILCA consensus recommendations for liver transplantation for HCC and intrahepatic cholangiocarcinoma
10.1097/lvt.0000000000000589 · 2025 · External reference
Liver transplantation in patients with liver metastases from neuroendocrine tumors: a systematic review
10.1016/j.surg.2017.05.006 · 2017 · External reference
Liver transplantation for unresectable colorectal liver metastases: a systematic review
10.1002/jso.24671 · 2017 · External reference
Liver transplantation plus chemotherapy versus chemotherapy alone in patients with permanently unresectable colorectal liver metastases (TransMet): results from a multicentre, open-label, prospective, randomised controlled trial
10.1016/s0140-6736(24)01595-2 · 2024 · External reference
Liver transplantation for nonresectable liver metastases from colorectal cancer
10.1097/sla.0b013e3182823957 · 2013 · External reference
Liver transplantation for non-resectable colorectal liver metastases: the international Hepato-Pancreato-biliary association consensus guidelines
10.1016/s2468-1253(21)00219-3 · 2021 · External reference
Over 30 years of living liver donation in North America: mortality associated with donation
10.1097/sla.0000000000006895 · 2025 · External reference
Estimates of early death, acute liver failure, and long-term mortality among live liver donors
10.1053/j.gastro.2011.11.015 · 2012 · External reference
A2ALL study group. Complications of living donor hepatic lobectomy-a comprehensive report
10.1111/j.1600-6143.2011.03972.x · 2012 · External reference
Right lobe versus left lobe living donor liver transplantation: a systematic review and meta-analysis of donor and recipient outcomes
10.1097/tp.0000000000004213 · 2022 · External reference
Right versus left: progress but no conclusion in selecting donors for live donor liver transplantation
10.1097/tp.0000000000004214 · 2022 · External reference
Left lobe living donor liver transplantation in adults
10.1111/j.1600-6143.2012.04022.x · 2012 · External reference
A novel concept for partial liver transplantation in nonresectable colorectal liver metastases: the RAPID concept
10.1097/sla.0000000000001165 · 2015 · External reference
Paradigm shift in the management of irresectable colorectal liver metastases: living donor auxiliary partial orthotopic liver transplantation in combination with two-stage hepatectomy (LD-RAPID)
10.1097/sla.0000000000002861 · 2019 · External reference
Living donor liver transplantation with two-stage hepatectomy for patients with isolated, irresectable colorectal liver metastases—the LIVER-T(W)O-HEAL study
10.1186/s12957-018-1549-5 · 2019 · External reference
Transplant benefit for patients with hepatocellular carcinoma
10.3748/wjg.v19.i48.9183 · 2013 · External reference
European hepatocellular Cancer liver transplant study group. Intention-to-treat survival benefit of liver transplantation in patients with hepatocellular cancer
10.1002/hep.29342 · 2017 · External reference
Should we use living donor grafts for patients with hepatocellular carcinoma? Ethical considerations
10.1002/lt.22356 · 2011 · External reference
A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list
10.1016/j.jhep.2013.10.010 · 2014 · External reference
Salvage living donor liver transplantation versus repeat liver resection for patients with recurrent hepatocellular carcinoma and child-Pugh class a liver cirrhosis: a propensity score-matched comparison
10.1111/ajt.16790 · 2022 · External reference
Salvage living donor liver transplantation for hepatocellular carcinoma recurrence after hepatectomy: quantitative prediction using ADV score
10.1002/jhbp.863 · 2021 · External reference
Continuing five or more locoregional therapies before living donor salvage liver transplantation for hepatocellular carcinoma is related to poor recurrence-free survival
10.4174/astr.2018.95.3.152 · 2018 · External reference
Living donor liver transplantation should be cautiously considered as initial treatment in recurrent hepatocellular carcinoma within the Milan criteria after curative liver resection
10.21037/atm.2020.02.170 · 2020 · External reference
Incorporating tumor biology to predict hepatocellular carcinoma recurrence in patients undergoing living donor liver transplantation using expanded selection criteria
10.1002/lt.25956 · 2021 · External reference
Experience with LDLT in patients with hepatocellular carcinoma and portal vein tumor thrombosis postdownstaging
10.1097/tp.0000000000003162 · 2020 · External reference
Prognostic impact of incidentally detected hepatocellular carcinoma in explanted livers after living donor liver transplantation
10.1007/s12664-020-01127-7 · 2021 · External reference
Oncologic outcomes after ABO-incompatible versus compatible living donor liver transplantation for hepatocellular carcinoma: a systematic review and meta-analysis
10.3390/cancers18111687 · 2026 · External reference
ABO blood type has no effect on hepatocellular carcinoma recurrence after living donor liver transplantation in the Korean organ transplantation registry study: a case-control study
10.1097/js9.0000000000004816 · 2026 · External reference
Liver transplantation for combined hepatocellular carcinoma and cholangiocarcinoma: a multicenter study
10.4240/wjgs.v15.i7.1340 · 2023 · External reference
Liver transplantation for neuroendocrine tumors in Europe: results and trends in patient selection
10.1097/sla.0b013e31828ee17c · 2013 · External reference
